Perspectives

Using Real World Data to Guide Precision Oncology Drug Development
Precision medicine is the commitment to deliver the right therapy to the right patient at the right time. This is a challenging goal, especially in oncology, given the wide diversity of diseases and patients. To address the challenges, drug developers are increasingly analyzing real world data (RWD) to generate real-world evidence (RWE) to complement what can be learned from traditional randomized, controlled clinical trials (RCTs).
View Nov 25, 2024
How to: Conduct an HTA Landscaping Review
Lumanity’s Linda Murphy provides insights into how to conduct an HTA landscaping review, tailoring it your company's needs, why it's useful, and key considerations.
Resource
Drill Down & Catch Up: The Role of Biomarkers in Neurodegenerative Disease
Lumanity offers extensive experience-based strategic guidance and insights in the field of neuroscience. Our goal is to provide our clients with actionable solutions that de-risk and optimize the development and commercialization of therapies, ultimately improving the lives of patients who are impacted across a range of conditions.
View Nov 4, 2024